COVID-۱۹ and the Risk of New-Onset Parkinson’s Disease and Multiple Sclerosis: A Systematic Review of the Evidence

  • سال انتشار: 1404
  • محل انتشار: فصلنامه تدارک دهندگان سلامت، دوره: 5، شماره: 1
  • کد COI اختصاصی: JR_HEPR-5-1_006
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 27
دانلود فایل این مقاله

نویسندگان

Sulemana Saibu

Clinical Research Directorate, Paediatric Research, GNCH, RVI, The Newcastle upon Tyne Hospitals NHS Foundation Trust ۲. Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, United Kingdom.

Moses Ikpeme

Senior Lecturer, Faculty of Medicine, School of Public Health, Imperial College, London, United Kingdom.

Onyinyechukwu Akaeje

Health, Safety, Environment and Quality Coordinator, Subsea ۷ Sutton London, United Kingdom.

چکیده

Background: Emerging evidence suggests COVID-۱۹ may increase the risk of long-term neurological complications, including Parkinson’s disease (PD) and multiple sclerosis (MS). This review examines the potential association between COVID-۱۹ and new-onset neurodegenerative diseases to clarify risks and guide future research and clinical care.Materials and Methods: This systematic review searched multiple databases-including Medline/PubMed, Embase, PsycINFO, SciELO, Web of Science, ProQuest, Scopus, CINAHL, and the WHO COVID-۱۹ database-as well as grey literature from January ۲۰۲۰ to December ۲۰۲۴ for studies reporting confirmed COVID-۱۹ followed by new diagnoses of PD or MS. Two reviewers independently screened and extracted data on demographics, clinical features, diagnostics, and outcomes, assessing study quality with a standardized checklist.Results: Twenty-one studies met inclusion criteria, including ۱۸ case reports and ۳ cohort studies, mostly from Europe and the Americas, with participants aged ۲۱–۷۶ years. Among ۲۷۹,۹۱۱ individuals, ۰.۱۴% developed PD and ۰.۰۰۷% developed MS after COVID-۱۹ infection. Diagnoses were confirmed clinically and through imaging, often with elevated inflammatory markers or genetic predispositions. Neurological symptoms appeared from a few days to one year post-infection, including motor deficits, cognitive decline, and sensory disturbances. Proposed mechanisms involved viral neurotropism, immune dysregulation, and persistent inflammation. Most patients received disease-specific treatments, with outcomes ranging from full recovery to persistent deficits. Although study quality was generally good, the predominance of case reports and moderate certainty of evidence require cautious interpretation.Conclusion: This review suggests a possible increased risk of neurodegenerative diseases such as MS and PD following COVID-۱۹, likely linked to immune and inflammatory processes. Well-designed, large-scale longitudinal studies are essential to confirm these findings and better understand the long-term neurological consequences.

کلیدواژه ها

COVID-۱۹, Multiple Sclerosis, neurological complications, Parkinson's disease

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.